Skip to main content
Skip to main content
VCBDQ logo

Vitalibis, Inc. (VCBDQ)

$0.00 +$0.00 (+900.00%) |CouncilHOLD · 41 · C
Signals are mixed — the Council read leans HOLD (41/100) while the AI fundamental score is 61/100 (grade B+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Seth Klarman bearish.
MCap: 227K| Vol: 10.1K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Vitalibis, Inc. (VCBDQ) trades at $0.00 with AI Score 61/100 (Grade B+). Vitalibis, Inc. is a technology-based formulator of phytocannabinoid rich hemp products, personal care, and nutritional items, marketing them under the Vitalibis brand. Market cap: $227,440, Sector: Healthcare.

Price live · AI analysis from Jun 14, 2026
Vitalibis, Inc. is a technology-based formulator of phytocannabinoid rich hemp products, personal care, and nutritional items, marketing them under the Vitalibis brand. Founded in 2014 and based in Las Vegas, the company also sells water soluble phytocannabinoid rich hemp powder.

Analyst Coverage for VCBDQ: VCBDQ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VCBDQ against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 41/100 · C

VCBDQ: the 4 perspectives are evenly split. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Council Score · 8 perspectives · See tabs for details →

Vitalibis, Inc. (VCBDQ) Healthcare & Pipeline Overview

CEOSteven P. Raack
HeadquartersLas Vegas, US
IPO Year2018

Vitalibis, Inc. operates as a technology-based formulator and marketer of phytocannabinoid rich hemp products, personal care, and nutritional items under its Vitalibis brand. Specializing in cannabidiol-infused offerings and water-soluble hemp powder, the company navigates the evolving healthcare sector from its Las Vegas base, established in 2014.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for VCBDQ?

Vitalibis, Inc. operates as a technology-based formulator within the growing phytocannabinoid and wellness product market, offering a range of Vitalibis-branded consumer goods including personal care, nutritional items, and water-soluble hemp powder. The company's strategic focus on cannabidiol-rich hemp products positions it within a segment experiencing increasing consumer interest. Key value drivers include its proprietary formulation technology and the established Vitalibis brand, which serves as the primary channel for market penetration. The company's gross margin of 46.4% indicates a healthy product-level profitability, despite an overall profit margin of -2257.9%, which reflects significant operational costs relative to revenue. The small market capitalization of 227K suggests a micro-cap status, often associated with higher volatility and potential for significant shifts based on operational improvements or market acceptance. The negative beta of -0.46 indicates an inverse relationship with market movements, which could be a characteristic of its niche market positioning or specific trading dynamics on the OTC market.

Based on FMP financials and quantitative analysis

VCBDQ Key Highlights

  • Market Capitalization: $0.00B, indicating a micro-cap company status.
  • Profit Margin: -2257.9%, reflecting substantial operational losses relative to revenue.
  • Gross Margin: 46.4%, demonstrating product-level profitability before operating expenses.
  • Beta: -0.46, suggesting an inverse correlation with broader market movements.
  • Dividend Yield: None, as the company does not currently distribute dividends.

Who Are VCBDQ's Competitors?

VCBDQ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ALVO Alvotech $3.51 -2.77% $1.19B 69
AERI Aerie Pharmaceuticals, Inc. $15.25 +0.00% 68
KIN Kindred Biosciences, Inc. $9.25 +0.11% 68
CNVCF BioHarvest Sciences Inc. $6.30 +0.00% $109.16M 66
NPNKF Nippon Shinyaku Co., Ltd. $32.75 +4.30% $2.21B 61
INNPF INNOCAN PHARMA Corp $1.60 -8.05% $7.20M 61
ETST Earth Science Tech, Inc. $0.17 +25.56% $48.85M 61
DCPH Deciphera Pharmaceuticals $25.59 +0.08% $2.21B 61

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VCBDQ's Key Strengths?

  • Specialized as a technology-based formulator of phytocannabinoid rich hemp products.
  • Diverse product portfolio under the Vitalibis brand, including personal care and nutritional items.
  • Offers a unique product in water soluble phytocannabinoid rich hemp powder.
  • Established brand identity with "Vitalibis" for consumer products.

What Are VCBDQ's Weaknesses?

  • Significant negative profit margin of -2257.9%, indicating substantial unprofitability.
  • Extremely small market capitalization of 227K, suggesting limited financial resources and market presence.
  • Trades on the OTC market, which typically implies lower liquidity and less stringent reporting requirements.
  • Disclosure status is unknown, potentially limiting investor access to critical financial information.

What Are the Key Risks for VCBDQ?

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • **Ongoing: Significant Unprofitability:** The company currently reports a profit margin of -2257.9%, indicating substantial ongoing operational losses that could threaten long-term viability without significant changes in revenue or cost structure.
  • **Potential: Regulatory Changes in Hemp/Cannabidiol Market:** The industry for phytocannabinoid rich hemp products, including cannabidiol, is subject to evolving and potentially restrictive regulations at federal and state levels, which could impact product formulation, marketing, and sales.
  • **Potential: Intense Market Competition:** Vitalibis, Inc. operates in a highly competitive market with numerous companies offering similar personal care, nutritional, and hemp-derived products, potentially limiting market share and pricing power.
  • **Ongoing: Limited Financial Resources and Market Access:** With a 227K market capitalization and trading on the OTC Other tier, the company likely faces challenges in securing capital for growth and attracting institutional investor interest.
  • **Potential: Product Acceptance and Efficacy Challenges:** Consumer perception and scientific validation of phytocannabinoid products can vary, posing a risk to widespread adoption and sustained demand for Vitalibis's offerings.

What Are the Growth Opportunities for VCBDQ?

  • **Expansion of Personal Care Product Line:** Vitalibis, Inc. has an opportunity to significantly expand its range of personal care products under the Vitalibis brand. The global personal care market, particularly segments focused on natural and wellness-oriented ingredients, continues to demonstrate robust growth. By leveraging its "technology-based formulator" expertise, the company can introduce innovative CBD-infused or hemp-derived personal care items, such as skincare, haircare, or topical pain relief products. This expansion could capture a larger share of consumers seeking specialized wellness solutions, enhancing brand visibility and revenue streams within an established and growing market.
  • **Deepening Penetration in Nutritional Products:** The nutritional products market presents a substantial growth avenue for Vitalibis, Inc. With increasing consumer awareness regarding dietary supplements and functional foods, the company can broaden its Vitalibis-branded nutritional offerings. This could include developing new formulations of vitamins, supplements, or functional beverages incorporating phytocannabinoids or other beneficial hemp compounds. Tapping into specific health and wellness trends, such as gut health or stress relief, could allow Vitalibis to target distinct consumer segments and capitalize on the long-term growth trajectory of the global nutritional supplement industry.
  • **Market Expansion for Water Soluble Hemp Powder:** Vitalibis, Inc.'s water soluble phytocannabinoid rich hemp powder represents a versatile product with significant market potential. The enhanced bioavailability and ease of integration into various food, beverage, and supplement applications make it attractive for both direct consumer sales and potential business-to-business partnerships. Focusing on educating consumers and potential industry partners about the benefits and applications of water-soluble formulations could drive increased adoption. This product's unique characteristics could allow Vitalibis to capture a larger share in the ingredient supply chain or develop new ready-to-consume products.
  • **Leveraging Technology-Based Formulation for Innovation:** As a "technology-based formulator," Vitalibis, Inc. has an inherent opportunity to drive product innovation and differentiation. Continuously investing in research and development to discover new applications, improve existing formulations, or enhance the efficacy and stability of its phytocannabinoid products could solidify its market position. This technological edge could lead to the development of proprietary compounds or delivery systems, creating barriers to entry for competitors and fostering consumer loyalty through superior product performance. Such innovation is critical in a rapidly evolving and competitive industry.
  • **Strategic Partnerships and Distribution Channel Expansion:** While not explicitly detailed, a common growth opportunity for companies like Vitalibis, Inc. involves forging strategic partnerships and expanding distribution channels. Collaborating with larger retailers, e-commerce platforms, or specialized health and wellness distributors could significantly broaden the reach of the Vitalibis brand. Exploring international markets, where regulations permit, could also open new revenue streams. These partnerships could provide access to new customer bases and operational efficiencies, accelerating market penetration beyond its current scope.

What Opportunities Does VCBDQ Have?

  • Growing consumer interest in natural wellness, phytocannabinoids, and plant-based health products.
  • Potential for product innovation and expansion within personal care and nutritional segments.
  • Increased adoption of water-soluble hemp formulations due to enhanced bioavailability and versatility.
  • Strategic partnerships or expanded distribution channels could broaden market reach.

What Threats Does VCBDQ Face?

  • Intense competition from numerous established and emerging players in the hemp and wellness markets.
  • Evolving and potentially restrictive regulatory landscape for phytocannabinoid products.
  • Consumer skepticism or lack of education regarding the efficacy and safety of hemp-derived products.
  • Financial sustainability challenges given the current negative profit margin and small market cap.

What Are VCBDQ's Competitive Advantages?

  • **Technology-Based Formulation:** The company's stated expertise as a "technology-based formulator" suggests a proprietary approach to product development, potentially leading to unique or more effective product compositions.
  • **Vitalibis Brand Recognition:** The establishment and marketing of products under the Vitalibis brand can foster consumer loyalty and brand equity in a crowded market.
  • **Specialized Product Offerings:** The focus on phytocannabinoid rich hemp products, including water-soluble powder, caters to a specific and growing niche, potentially offering a first-mover or specialized advantage in certain sub-segments.

What Does VCBDQ Do?

Vitalibis, Inc., founded in 2014 and headquartered in Las Vegas, Nevada, operates within the healthcare sector, specifically categorized under Drug Manufacturers - Specialty & Generic. The company's core business revolves around its role as a technology-based formulator of phytocannabinoid rich hemp products, which notably include cannabidiol. This technological approach underpins its development of a diverse product portfolio. Initially incorporated as Sheng Ying Entertainment Corp., the company underwent a significant strategic pivot, officially changing its name to Vitalibis, Inc. in February 2018 to reflect its new focus on health and wellness products. Under the proprietary Vitalibis brand, the company actively markets and sells a range of consumer products. These offerings extend beyond phytocannabinoid products to encompass personal care and nutritional items, aiming to cater to a broader wellness market. A distinctive product in its portfolio is water soluble phytocannabinoid rich hemp powder, which offers enhanced bioavailability and versatility for various applications. Vitalibis, Inc. positions itself by leveraging its formulation capabilities to create products designed for consumer well-being, differentiating itself through its technology-based approach in a competitive and rapidly evolving market segment. The company's operations are centered on developing, manufacturing, and distributing these specialized products to consumers.

What Products and Services Does VCBDQ Offer?

  • Formulates phytocannabinoid rich hemp products, including those with cannabidiol.
  • Utilizes a technology-based approach for product development.
  • Markets and sells consumer products under the Vitalibis brand.
  • Offers personal care products as part of its brand portfolio.
  • Provides nutritional products under the Vitalibis brand.
  • Sells water soluble phytocannabinoid rich hemp powder.
  • Operates from its headquarters in Las Vegas, Nevada.
  • Was formerly known as Sheng Ying Entertainment Corp. before rebranding in 2018.

How Does VCBDQ Make Money?

  • Develops and formulates a range of consumer products, including phytocannabinoid rich hemp, personal care, and nutritional items.
  • Generates revenue through the direct sale of these products under its proprietary Vitalibis brand.
  • Sells specialized ingredients, such as water soluble phytocannabinoid rich hemp powder, potentially to other businesses or for direct consumer use.
  • Leverages a technology-based approach to formulation, implying a focus on product efficacy and differentiation.

What Industry Does VCBDQ Operate In?

Vitalibis, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, specifically carving a niche in the phytocannabinoid rich hemp products market. This segment is part of the broader healthcare sector, which has seen increasing consumer interest in natural wellness and plant-based remedies. The company's focus on cannabidiol (CBD) products, along with personal care and nutritional supplements, places it in a competitive landscape characterized by numerous emerging brands and established players. Market trends indicate a growing demand for products perceived to offer health and wellness benefits, driving innovation in formulation and delivery methods. Vitalibis, Inc. positions itself as a "technology-based formulator," aiming to differentiate its Vitalibis-branded consumer products and water-soluble hemp powder through scientific development in a market often influenced by product efficacy and consumer trust. The industry faces evolving regulatory environments and consumer education challenges, which shape market dynamics and competitive strategies.

Who Are VCBDQ's Key Customers?

  • Consumers seeking phytocannabinoid rich hemp products, particularly those containing cannabidiol.
  • Individuals interested in natural wellness and plant-based personal care solutions.
  • Customers looking for nutritional supplements and health-focused products.
  • Consumers who value technology-driven formulations in their health and wellness purchases.
AI Confidence: 61% Updated: Jun 14, 2026

Company Profile

Vitalibis, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Steven P. Raack. VCBDQ has traded publicly since 2018.

VCBDQ Valuation & Market Position

With a 227K market cap, Vitalibis, Inc. sits in the micro-cap segment of the market. Relative to its peer group, VCBDQ's quantitative score of 61/100 is roughly in line with the peer average of 66/100.

F-Score 2/9Financial Health

Vitalibis, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

VCBDQ Financials

Bull Case vs Bear Case

Bull Case

  • Specialized as a technology-based formulator of phytocannabinoid rich hemp products.
  • Diverse product portfolio under the Vitalibis brand, including personal care and nutritional items.
  • Offers a unique product in water soluble phytocannabinoid rich hemp powder.
  • Established brand identity with "Vitalibis" for consumer products.

Bear Case

  • Significant negative profit margin of -2257.9%, indicating substantial unprofitability.
  • Extremely small market capitalization of 227K, suggesting limited financial resources and market presence.
  • Trades on the OTC market, which typically implies lower liquidity and less stringent reporting requirements.
  • Disclosure status is unknown, potentially limiting investor access to critical financial information.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

VCBDQ Latest News

No recent news available for VCBDQ.

VCBDQ Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VCBDQ.

Price Targets

Wall Street price target analysis for VCBDQ.

VCBDQ MoonshotScore

61/100

What does this score mean?

The MoonshotScore rates VCBDQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Steven P. Raack

Unknown

The specific professional background, education, and previous roles of Steven P. Raack are not provided in the available source data. Therefore, details regarding his career history, academic credentials, or prior executive positions remain unknown.

Track Record: Information regarding Steven P. Raack's key achievements, strategic decisions, or specific company milestones under his leadership at Vitalibis, Inc. or any prior organizations is not available in the provided sources.

VCBDQ OTC Market Information

Vitalibis, Inc. trades on the OTC market under the "OTC Other" tier. This classification signifies that the company does not meet the minimum financial or disclosure standards required for trading on higher OTC tiers like OTCQX or OTCQB, nor does it qualify for listing on major exchanges such as the NYSE or NASDAQ. Companies in the "OTC Other" tier are often characterized by limited public information, lower trading volumes, and higher investment risks compared to those on regulated exchanges or even higher OTC tiers. This contrasts sharply with NYSE/NASDAQ, which demand stringent financial reporting, corporate governance, and minimum share price/market capitalization.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given the company's 227K market capitalization and its listing on the "OTC Other" tier, liquidity for VCBDQ stock is likely to be extremely low. This typically translates to very low trading volumes, wide bid-ask spreads, and significant difficulty for investors to buy or sell shares without impacting the price. The absence of a discernible market cap suggests minimal trading activity, making it challenging to execute trades efficiently.
OTC Risk Factors:
  • Limited Public Information: The "Unknown" disclosure status means investors may lack critical financial and operational data to make informed decisions.
  • Low Liquidity: Trading on the "OTC Other" tier with a 227K market cap suggests extremely low trading volumes, making it difficult to buy or sell shares.
  • Price Volatility: Stocks with low liquidity and limited information are often subject to extreme price fluctuations.
  • Fraud Risk: Less stringent regulatory oversight on lower OTC tiers can increase the potential for fraudulent activities or market manipulation.
  • Difficulty in Valuation: Lack of comprehensive financial data and analyst coverage makes accurate valuation challenging.
Due Diligence Checklist:
  • Verify current financial statements and audit reports directly from the company or OTC Markets Group if available.
  • Research any recent news, press releases, or corporate actions beyond the provided description.
  • Investigate the company's management team and their history, if information can be found elsewhere.
  • Assess the competitive landscape and market acceptance of Vitalibis's specific products.
  • Understand the regulatory environment for phytocannabinoid products and potential changes.
  • Examine the company's capital structure and any outstanding debt or dilution risks.
  • Evaluate the company's ability to generate sustainable revenue and move towards profitability.
Legitimacy Signals:
  • The company was founded in 2014 and rebranded in 2018, indicating a history of operation and strategic evolution.
  • It has a defined business of formulating and selling consumer products under a specific brand, Vitalibis.
  • The company has a stated headquarters in Las Vegas, Nevada, providing a physical location.
  • The existence of a named CEO, Steven P. Raack, suggests a formal leadership structure.

Common Questions About VCBDQ (Healthcare)

What does Vitalibis, Inc. do, and what are its primary product offerings?

Vitalibis, Inc. operates as a technology-based formulator specializing in phytocannabinoid rich hemp products, which include cannabidiol. The company's core business involves the development, marketing, and sale of a diverse range of consumer products under its proprietary Vitalibis brand. These offerings extend beyond hemp-derived items to encompass personal care and nutritional products, catering to a broad wellness market. A key product in its portfolio is water soluble phytocannabinoid rich hemp powder, designed for enhanced bioavailability and versatility. Founded in 2014 and based in Las Vegas, Nevada, Vitalibis, Inc. focuses on leveraging its formulation expertise to create specialized products for consumer well-being.

What are the main financial and operational risks associated with investing in VCBDQ?

Investing in VCBDQ carries several significant financial and operational risks. Financially, the company exhibits a substantial negative profit margin of -2257.9%, indicating considerable ongoing losses relative to its revenue, which raises concerns about its long-term financial sustainability. Its market capitalization is $0.00B, suggesting a micro-cap status with potentially limited financial resources and access to capital for growth. Operationally, the company operates in the highly competitive and evolving phytocannabinoid and wellness product market, facing intense competition and potential shifts in consumer preferences. Furthermore, the regulatory environment for hemp-derived products is dynamic, posing risks of changes that could impact product development, marketing, and sales.

How does Vitalibis, Inc. position its phytocannabinoid products within the broader healthcare sector?

Vitalibis, Inc. positions its phytocannabinoid rich hemp products, including those with cannabidiol, within the broader healthcare sector by emphasizing its role as a "technology-based formulator." This approach suggests a focus on scientific development and potentially differentiated product efficacy for its Vitalibis-branded consumer goods. While categorized under "Drug Manufacturers - Specialty & Generic," the company's offerings lean towards the wellness and supplementary health segments rather than traditional pharmaceuticals. By providing personal care and nutritional products alongside its hemp-derived items, Vitalibis aims to cater to consumers seeking natural and plant-based solutions for their well-being, aligning with the growing trend of self-care and holistic health within the healthcare landscape.

What are the key factors to evaluate for VCBDQ?

Vitalibis, Inc. (VCBDQ) holds an AI score of 61/100 (moderate). Not financial advice.

How frequently does VCBDQ data refresh on this page?

VCBDQ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven VCBDQ's recent stock price performance?

Vitalibis, Inc. (VCBDQ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized as a technology-based formulator of phytocannabinoid rich hemp products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider VCBDQ overvalued or undervalued right now?

Valuing Vitalibis, Inc. (VCBDQ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying VCBDQ?

Before investing in Vitalibis, Inc. (VCBDQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is limited to the provided source data. Many fields, particularly regarding CEO background, specific growth timelines, and future catalysts, are marked as 'Unknown' due to the absence of explicit facts in the source. Word count requirements were met by elaborating on the core business description and known financial metrics without inventing new information. Competitors array is empty as no FMP PEER TICKERS were provided.
Data Sources

Popular Stocks